PedAM
Pediatric Disease Annotations & Medicines
| Disease | visceral leishmaniasis |
| Symptom | C0023283|cutaneous leishmaniasis |
| Sentences | 1 |
| PubMedID- 22566961 | Protective immunity against visceral leishmaniasis, as with species causing cutaneous leishmaniasis, is dependent on an il-12 driven type-1 response and ifn-γ production (murray, 1997; engwerda et al., 1998), which results in the induction of parasite killing by macrophages primarily via the production of reactive nitrogen and oxygen intermediates (murray and nathan, 1999). |
Page: 1